Darby Private Equity, the private capital arm of Franklin Templeton Investments, has completed an investment in Panama-based specialty pharmaceutical distributor Pharma Consulting Group (Biopas). The company, which offers immunology, rare disease, central nervous system, oncology, specialty care, and dermatology products across 13 countries in Latin America, will use the new capital to grow its product portfolio and expand into new markets in the region. Financial details of the transaction, which was completed through Darby Latin American Private Debt Fund III, were not disclosed.